Raymond James & Associates’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$118M Buy
403,226
+17,848
+5% +$5.03M 0.07% 234
2024
Q2
$93.4M Buy
385,378
+13,540
+4% +$3.23M 0.06% 267
2024
Q1
$99.5M Buy
371,838
+29,896
+9% +$7.61M 0.07% 258
2023
Q4
$84.6M Buy
341,942
+142,571
+72% +$28.9M 0.06% 262
2023
Q3
$36.5M Buy
199,371
+3,562
+2% +$727K 0.03% 456
2023
Q2
$46.1M Buy
195,809
+4,353
+2% +$916K 0.04% 380
2023
Q1
$38.8M Buy
191,456
+8,122
+4% +$1.69M 0.03% 423
2022
Q4
$35.6M Buy
183,334
+6,377
+4% +$1.17M 0.03% 438
2022
Q3
$30.3M Buy
176,957
+115,956
+190% +$22.7M 0.03% 449
2022
Q2
$11.2M Buy
61,001
+4,167
+7% +$834K 0.01% 920
2022
Q1
$13.5M Sell
56,834
-102,623
-64% -$24.2M 0.01% 913
2021
Q4
$46.7M Buy
159,457
+16,746
+12% +$4.66M 0.04% 406
2021
Q3
$36.2M Buy
142,711
+15,199
+12% +$3.95M 0.03% 457
2021
Q2
$30.5M Sell
127,512
-5,914
-4% -$1.32M 0.03% 511
2021
Q1
$24.2M Buy
133,426
+8,136
+6% +$1.44M 0.02% 578
2020
Q4
$24.2M Sell
125,290
-5,641
-4% -$948K 0.03% 532
2020
Q3
$20.5M Buy
130,931
+32,639
+33% +$5.35M 0.03% 526
2020
Q2
$16.9M Buy
98,292
+14,538
+17% +$2.15M 0.02% 590
2020
Q1
$10M Buy
83,754
+43,157
+106% +$6.28M 0.02% 751
2019
Q4
$5.69M Buy
40,597
+143
+0.4% +$19.8K 0.01% 1176
2019
Q3
$5.69M Buy
40,454
+9,184
+29% +$1.29M 0.01% 1147
2019
Q2
$4.23M Buy
31,270
+5,948
+23% +$746K 0.01% 1318
2019
Q1
$3M Sell
25,322
-181
-0.7% -$19.3K ﹤0.01% 1509
2018
Q4
$2.38M Sell
25,503
-2,039
-7% -$217K ﹤0.01% 1540
2018
Q3
$3.6M Buy
27,542
+493
+2% +$64.2K 0.01% 1428
2018
Q2
$3.38M Buy
27,049
+1,935
+8% +$229K 0.01% 1418
2018
Q1
$2.96M Sell
25,114
-61,006
-71% -$7.32M 0.01% 1450
2017
Q4
$10.2M Sell
86,120
-80,907
-48% -$9.09M 0.02% 750
2017
Q3
$17.7M Buy
167,027
+5,348
+3% +$707K 0.04% 501
2017
Q2
$22.2M Buy
161,679
+5,786
+4% +$794K 0.05% 381
2017
Q1
$21.3M Buy
155,893
+54,828
+54% +$6.97M 0.05% 367
2016
Q4
$11.9M Sell
101,065
-3,425
-3% -$419K 0.03% 550
2016
Q3
$14.1M Sell
104,490
-16,879
-14% -$2.24M 0.04% 461
2016
Q2
$15.6M Sell
121,369
-12,817
-10% -$1.55M 0.05% 394
2016
Q1
$15.3M Sell
134,186
-3,643
-3% -$383K 0.05% 387
2015
Q4
$15.3M Sell
137,829
-877
-0.6% -$94.7K 0.06% 374
2015
Q3
$13.5M Buy
138,706
+22,020
+19% +$2.19M 0.06% 384
2015
Q2
$11.3M Buy
116,686
+24,844
+27% +$2.42M 0.04% 470
2015
Q1
$8.54M Buy
91,842
+22,144
+32% +$1.97M 0.04% 509
2014
Q4
$5.64M Sell
69,698
-19,417
-22% -$1.5M 0.03% 622
2014
Q3
$6.66M Buy
89,115
+5,661
+7% +$431K 0.04% 506
2014
Q2
$6.05M Buy
83,454
+9,382
+13% +$658K 0.04% 547
2014
Q1
$5.04M Buy
74,072
+28,202
+61% +$1.97M 0.03% 566
2013
Q4
$3.17M Buy
45,870
+5,584
+14% +$363K 0.02% 725
2013
Q3
$2.41M Buy
40,286
+19,047
+90% +$1.17M 0.02% 784
2013
Q2
$1.25M Buy
+21,239
New +$1.28M 0.01% 1060

Other funds holding EFX

Raymond James & Associates's EFX Position: Q3 2024 in Review

Raymond James & Associates increased its Equifax (EFX) stake by 4.6% in Q3 2024, buying an estimated $5.03M and bringing the position to 403,226 shares worth $118M. The position accounts for 0.07% of the portfolio, ranked #234.

Raymond James & Associates first reported a position in EFX in Q2 2013 and has held it in 46 quarters since. 835 funds tracked by Wall St. Rank hold EFX as of Q3 2024.

  • Raymond James & Associates held 403,226 shares of Equifax worth $118M as of Q3 2024.
  • Raymond James & Associates bought 17,848 Equifax shares in Q3 2024, an estimated $5.03M.
  • Equifax made up 0.07% of Raymond James & Associates's portfolio in Q3 2024, its #234 holding.
  • Raymond James & Associates first reported a position in Equifax in Q2 2013 and has held it in 46 quarters since.
  • 835 funds tracked by Wall St. Rank held Equifax as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.